> For serotonergic  medicinal products  (e.g. SSRIs  and SNRIs , BUPRENORPHINE, opiods or other serotonergic medicinal products ), there  have  been  reports  of serotonin  syndrome  following  concomitant  use of 5-HT
3 antagonists  and other  serotonergic  medicinal products  (including  SSRIs  and SNRIs). 
> In human  subjects,  hepatic  enzyme  induction by PHENOBARBITAL  has led to an  increase in  total plasma  clearance  (approximately  25%)  following  intravenous  administration  of granisetron.
